1. Home
  2. VTAK vs EZRA Comparison

VTAK vs EZRA Comparison

Compare VTAK & EZRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Catheter Precision Inc.

VTAK

Catheter Precision Inc.

HOLD

Current Price

$1.38

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

Logo Reliance Global Group Inc. Common Stock

EZRA

Reliance Global Group Inc. Common Stock

N/A

Current Price

$0.19

Market Cap

2.4M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
VTAK
EZRA
Founded
2002
2013
Country
United States
United States
Employees
N/A
64
Industry
Medical/Dental Instruments
Specialty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.9M
2.4M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
VTAK
EZRA
Price
$1.38
$0.19
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
784.7K
10.4M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
89.53
N/A
EPS
N/A
N/A
Revenue
$442,000.00
N/A
Revenue This Year
$822.86
N/A
Revenue Next Year
$168.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3057.14
N/A
52 Week Low
$0.15
$0.15
52 Week High
$4.31
$0.39

Technical Indicators

Market Signals
Indicator
VTAK
EZRA
Relative Strength Index (RSI) 40.50 43.85
Support Level $1.14 $0.18
Resistance Level $2.05 $0.28
Average True Range (ATR) 0.13 0.05
MACD 0.00 -0.01
Stochastic Oscillator 6.71 0.35

Price Performance

Historical Comparison
VTAK
EZRA

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

About EZRA Reliance Global Group Inc. Common Stock

Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing acquisition strategies, initially and focused on wholesale and retail insurance agencies. Its primary strategies is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.

Share on Social Networks: